Global and United States Biologics Drug Development Market Report & Forecast 2023-2028

Report ID: 1830762 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Biologics Drug Development Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Biologics Drug Development Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Biologics Drug Development Market Size for the Year 2017-2028
        1.2.2 Global Biologics Drug Development Market Size for the Year 2017-2028
    1.3 Biologics Drug Development Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Biologics Drug Development in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Biologics Drug Development Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Biologics Drug Development Market Dynamics
        1.4.1 Biologics Drug Development Industry Trends
        1.4.2 Biologics Drug Development Market Drivers
        1.4.3 Biologics Drug Development Market Challenges
        1.4.4 Biologics Drug Development Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Biologics Drug Development by Type
    2.1 Biologics Drug Development Market Segment by Type
        2.1.1 Clinical Manufacturing
        2.1.2 Formulation Development
        2.1.3 Bioassay Development
        2.1.4 Analytical Services
    2.2 Global Biologics Drug Development Market Size by Type (2017, 2022 & 2028)
    2.3 Global Biologics Drug Development Market Size by Type (2017-2028)
    2.4 United States Biologics Drug Development Market Size by Type (2017, 2022 & 2028)
    2.5 United States Biologics Drug Development Market Size by Type (2017-2028)
3 Biologics Drug Development by Application
    3.1 Biologics Drug Development Market Segment by Application
        3.1.1 In-House
        3.1.2 Outsource
        3.1.3 Pharma Excess
    3.2 Global Biologics Drug Development Market Size by Application (2017, 2022 & 2028)
    3.3 Global Biologics Drug Development Market Size by Application (2017-2028)
    3.4 United States Biologics Drug Development Market Size by Application (2017, 2022 & 2028)
    3.5 United States Biologics Drug Development Market Size by Application (2017-2028)
4 Global Biologics Drug Development Competitor Landscape by Company
    4.1 Global Biologics Drug Development Market Size by Company
        4.1.1 Top Global Biologics Drug Development Companies Ranked by Revenue (2021)
        4.1.2 Global Biologics Drug Development Revenue by Player (2017-2022)
    4.2 Global Biologics Drug Development Concentration Ratio (CR)
        4.2.1 Biologics Drug Development Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Biologics Drug Development in 2021
        4.2.3 Global Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Biologics Drug Development Headquarters, Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Biologics Drug Development Headquarters and Area Served
        4.3.2 Global Biologics Drug Development Companies Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Biologics Drug Development Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Biologics Drug Development Market Size by Company
        4.5.1 Top Biologics Drug Development Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Biologics Drug Development Revenue by Players (2020, 2021 & 2022)
5 Global Biologics Drug Development Market Size by Region
    5.1 Global Biologics Drug Development Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Biologics Drug Development Market Size by Region (2017-2028)
        5.2.1 Global Biologics Drug Development Market Size by Region: 2017-2022
        5.2.2 Global Biologics Drug Development Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Biologics Drug Development Market Size YoY Growth 2017-2028
        6.1.2 North America Biologics Drug Development Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Biologics Drug Development Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Biologics Drug Development Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Biologics Drug Development Market Size YoY Growth 2017-2028
        6.3.2 Europe Biologics Drug Development Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Biologics Drug Development Market Size YoY Growth 2017-2028
        6.4.2 Latin America Biologics Drug Development Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Biologics Drug Development Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Biologics Drug Development Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Abbvie
        7.1.1 Abbvie Company Details
        7.1.2 Abbvie Business Overview
        7.1.3 Abbvie Biologics Drug Development Introduction
        7.1.4 Abbvie Revenue in Biologics Drug Development Business (2017-2022)
        7.1.5 Abbvie Recent Development
    7.2 Allergan
        7.2.1 Allergan Company Details
        7.2.2 Allergan Business Overview
        7.2.3 Allergan Biologics Drug Development Introduction
        7.2.4 Allergan Revenue in Biologics Drug Development Business (2017-2022)
        7.2.5 Allergan Recent Development
    7.3 Boehringer Ingelheim
        7.3.1 Boehringer Ingelheim Company Details
        7.3.2 Boehringer Ingelheim Business Overview
        7.3.3 Boehringer Ingelheim Biologics Drug Development Introduction
        7.3.4 Boehringer Ingelheim Revenue in Biologics Drug Development Business (2017-2022)
        7.3.5 Boehringer Ingelheim Recent Development
    7.4 Charles River Laboratories
        7.4.1 Charles River Laboratories Company Details
        7.4.2 Charles River Laboratories Business Overview
        7.4.3 Charles River Laboratories Biologics Drug Development Introduction
        7.4.4 Charles River Laboratories Revenue in Biologics Drug Development Business (2017-2022)
        7.4.5 Charles River Laboratories Recent Development
    7.5 Catalent
        7.5.1 Catalent Company Details
        7.5.2 Catalent Business Overview
        7.5.3 Catalent Biologics Drug Development Introduction
        7.5.4 Catalent Revenue in Biologics Drug Development Business (2017-2022)
        7.5.5 Catalent Recent Development
    7.6 Lonza Group
        7.6.1 Lonza Group Company Details
        7.6.2 Lonza Group Business Overview
        7.6.3 Lonza Group Biologics Drug Development Introduction
        7.6.4 Lonza Group Revenue in Biologics Drug Development Business (2017-2022)
        7.6.5 Lonza Group Recent Development
    7.7 Amgen
        7.7.1 Amgen Company Details
        7.7.2 Amgen Business Overview
        7.7.3 Amgen Biologics Drug Development Introduction
        7.7.4 Amgen Revenue in Biologics Drug Development Business (2017-2022)
        7.7.5 Amgen Recent Development
    7.8 Sanofi
        7.8.1 Sanofi Company Details
        7.8.2 Sanofi Business Overview
        7.8.3 Sanofi Biologics Drug Development Introduction
        7.8.4 Sanofi Revenue in Biologics Drug Development Business (2017-2022)
        7.8.5 Sanofi Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Biologics Drug Development Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Biologics Drug Development Market Trends
    Table 3. Biologics Drug Development Market Drivers
    Table 4. Biologics Drug Development Market Challenges
    Table 5. Biologics Drug Development Market Restraints
    Table 6. Global Biologics Drug Development Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Biologics Drug Development Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Biologics Drug Development Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Biologics Drug Development Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Biologics Drug Development Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Biologics Drug Development Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Biologics Drug Development Revenue Share by Player, 2017-2022
    Table 13. Global Biologics Drug Development Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Biologics Drug Development by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Development as of 2021)
    Table 15. Top Players of Biologics Drug Development in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Biologics Drug Development Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Biologics Drug Development Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Biologics Drug Development Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Biologics Drug Development Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Biologics Drug Development Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Biologics Drug Development Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Biologics Drug Development Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Biologics Drug Development Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Biologics Drug Development Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Biologics Drug Development Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Biologics Drug Development Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Biologics Drug Development Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbvie Company Details
    Table 31. Abbvie Business Overview
    Table 32. Abbvie Biologics Drug Development Product
    Table 33. Abbvie Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million)
    Table 34. Abbvie Recent Development
    Table 35. Allergan Company Details
    Table 36. Allergan Business Overview
    Table 37. Allergan Biologics Drug Development Product
    Table 38. Allergan Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million)
    Table 39. Allergan Recent Development
    Table 40. Boehringer Ingelheim Company Details
    Table 41. Boehringer Ingelheim Business Overview
    Table 42. Boehringer Ingelheim Biologics Drug Development Product
    Table 43. Boehringer Ingelheim Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million)
    Table 44. Boehringer Ingelheim Recent Development
    Table 45. Charles River Laboratories Company Details
    Table 46. Charles River Laboratories Business Overview
    Table 47. Charles River Laboratories Biologics Drug Development Product
    Table 48. Charles River Laboratories Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million)
    Table 49. Charles River Laboratories Recent Development
    Table 50. Catalent Company Details
    Table 51. Catalent Business Overview
    Table 52. Catalent Biologics Drug Development Product
    Table 53. Catalent Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million)
    Table 54. Catalent Recent Development
    Table 55. Lonza Group Company Details
    Table 56. Lonza Group Business Overview
    Table 57. Lonza Group Biologics Drug Development Product
    Table 58. Lonza Group Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million)
    Table 59. Lonza Group Recent Development
    Table 60. Amgen Company Details
    Table 61. Amgen Business Overview
    Table 62. Amgen Biologics Drug Development Product
    Table 63. Amgen Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million)
    Table 64. Amgen Recent Development
    Table 65. Sanofi Company Details
    Table 66. Sanofi Business Overview
    Table 67. Sanofi Biologics Drug Development Product
    Table 68. Sanofi Revenue in Biologics Drug Development Business (2017-2022) & (US$ Million)
    Table 69. Sanofi Recent Development
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biologics Drug Development Product Picture
    Figure 2. Global Biologics Drug Development Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Biologics Drug Development Market Size 2017-2028 (US$ Million)
    Figure 4. United States Biologics Drug Development Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Biologics Drug Development Market Size 2017-2028 (US$ Million)
    Figure 6. United States Biologics Drug Development Market Share in Global 2017-2028
    Figure 7. Biologics Drug Development Report Years Considered
    Figure 8. Product Picture of Clinical Manufacturing
    Figure 9. Product Picture of Formulation Development
    Figure 10. Product Picture of Bioassay Development
    Figure 11. Product Picture of Analytical Services
    Figure 12. Global Biologics Drug Development Market Share by Type in 2022 & 2028
    Figure 13. Global Biologics Drug Development Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Biologics Drug Development Market Share by Type (2017-2028)
    Figure 15. United States Biologics Drug Development Market Share by Type in 2022 & 2028
    Figure 16. United States Biologics Drug Development Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Biologics Drug Development Market Share by Type (2017-2028)
    Figure 18. Product Picture of In-House
    Figure 19. Product Picture of Outsource
    Figure 20. Product Picture of Pharma Excess
    Figure 21. Global Biologics Drug Development Market Share by Application in 2022 & 2028
    Figure 22. Global Biologics Drug Development Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Biologics Drug Development Market Share by Application (2017-2028)
    Figure 24. United States Biologics Drug Development Market Share by Application in 2022 & 2028
    Figure 25. United States Biologics Drug Development Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Biologics Drug Development Market Share by Application (2017-2028)
    Figure 27. North America Biologics Drug Development Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Biologics Drug Development Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Biologics Drug Development Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Biologics Drug Development Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Biologics Drug Development Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Biologics Drug Development Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Abbvie Revenue Growth Rate in Biologics Drug Development Business (2017-2022)
    Figure 56. Allergan Revenue Growth Rate in Biologics Drug Development Business (2017-2022)
    Figure 57. Boehringer Ingelheim Revenue Growth Rate in Biologics Drug Development Business (2017-2022)
    Figure 58. Charles River Laboratories Revenue Growth Rate in Biologics Drug Development Business (2017-2022)
    Figure 59. Catalent Revenue Growth Rate in Biologics Drug Development Business (2017-2022)
    Figure 60. Lonza Group Revenue Growth Rate in Biologics Drug Development Business (2017-2022)
    Figure 61. Amgen Revenue Growth Rate in Biologics Drug Development Business (2017-2022)
    Figure 62. Sanofi Revenue Growth Rate in Biologics Drug Development Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Frequently Asked Questions
Biologics Drug Development report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biologics Drug Development report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biologics Drug Development report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports